This targeted drug delivery technological innovation is built to permit ENT physicians to control individual treatment. The corporation's commercial goods will be the PROPEL and PROPEL Mini drug-releasing implants for sufferers undergoing sinus medical procedures to deal with Continual sinusitis.Biotage AB is a Sweden-based enterprise that develops